Sichuan Ingia Biosynthetic Co.
Latest round
- Series A
Last raised
- Sep 2025
Total raised
- Undisclosed
Investors
- 2
About Sichuan Ingia Biosynthetic Co.
, Ltd. operates as a synthetic biology technology developer, manufacturing the stevia glycosides by biological method. The company established Chengdu Research and Development Center for Synthetic Biology of Natural Products with Shanghai Institutes of Life Sciences, Chinese Academy of Sciences. The company has obtained more than 20 domestic and foreign patent certifications., Ltd. The products manufactured by the company include stevia glycosides, coenzyme Q10, vanillin, monk fruit glycosides and nicotinamide mononucleotide. The products of the company can be used in making soda water, yoga, bread, cake, biscuit, ice cream and etc. The company generates revenue from providing natural sweeteners, natural flavors and fragrances and dietary supplements products. The company will focuses on accelerating the company's layout in the field of synthetic biology.
Who invested in Sichuan Ingia Biosynthetic Co.
2 investors across 2 rounds
See all investors in Sichuan Ingia Biosynthetic Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Sichuan Ingia Biosynthetic Co.
Who invested in Sichuan Ingia Biosynthetic Co.?
Sichuan Ingia Biosynthetic Co. has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Sichuan Ingia Biosynthetic Co. raised?
Sichuan Ingia Biosynthetic Co. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Sichuan Ingia Biosynthetic Co. last raise money?
Sichuan Ingia Biosynthetic Co.'s most recent round on record is a Series A, in Sep 2025.
What does Sichuan Ingia Biosynthetic Co. do?
Sichuan Ingia Biosynthetic Co. is a biotechnology company.
Where is Sichuan Ingia Biosynthetic Co. headquartered?
Sichuan Ingia Biosynthetic Co. is headquartered in Chengdu, China.
Which VCs invest in companies like Sichuan Ingia Biosynthetic Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Sichuan Ingia Biosynthetic Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Sichuan Ingia Biosynthetic Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.